This is the logo of the provider
5 June 2026

Patient-centric obesity care: from evidence and guidelines to future directions 

Meeting description
Add to Calendar
Download agenda
Friday, 05 June 2026
18:30 - 18:33
(CDT)

Welcome & introduction

Donna Ryan
18:33 - 18:40
(CDT)

What’s new in obesity management guidelines?

Louis J. Aronne
18:40 - 18:55
(CDT)

Latest developments in approved pharmacological options – where is the evidence pointing?

Deborah Bade Horn
18:55 - 19:10
(CDT)

From weight to health outcomes – what is proven?

Jaime Almandoz
19:10 - 19:25
(CDT)

Panel discussion

Donna Ryan, Louis J. Aronne, Deborah Bade Horn, Jaime Almandoz, Thomas Lutz, Domenica Rubino
19:25 - 19:32
(CDT)

Moving beyond current pharmacological options

Donna Ryan
19:32 - 19:42
(CDT)

What is the role of amylin biology in weight management?

Thomas Lutz
19:42 - 19:57
(CDT)

What do emerging clinical data focused on amylin analogues show?

Louis J. Aronne
19:57 - 20:07
(CDT)

From early-phase data to programme design – what is the development path for potential future therapies?

Domenica Rubino
20:07 - 20:25
(CDT)

Panel discussion

Donna Ryan, Louis J. Aronne, Deborah Bade Horn, Jaime Almandoz, Thomas Lutz, Domenica Rubino
20:25 - 20:30
(CDT)

Key takeaways & close

Donna Ryan
Keywords
Congress industry session
Amylin
GLP-1 RA
Cagrilintide
CagriSema
Semaglutide
Semaglutide (oral)
PHASE 1 (RCT)
PHASE 2 (RCT)
PHASE 3 (RCT)
Non-clinical
RWE HEOR